Latest Breaking News On - Samantha semenkow - Page 1 : vimarsana.com

Shares of this gene editing company are due to surge more than 45%, Citi says

Investors should pick up shares of biotech Prime Medicine as it regains the market's favor after a period of steady underperformance, according to Citi.

United kingdomSamantha semenkowDrug administrationPrime medicineAnalyst samantha semenkow

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript

Catalyst Pharmaceuticals, Inc (NASDAQ:CPRX) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesSteven millerDydo pharmaMichael kalbMike kalbJason gerberryJoon leeRichard dalySamantha semenkowPiper sandlerCharles duncanJoe catanzaroCenters of excellenceCantor fitzgerald2iq researchCatalyst pharmaceuticals inc

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15 Is It a Buy Around $5?

1 Wall Street Analyst Thinks Editas Medicine Stock Is Going to $15 Is It a Buy Around $5?
fool.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com Daily Mail and Mail on Sunday newspapers.

Samantha semenkowEditas medicine

Editas Medicine, Inc (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript

Editas Medicine, Inc (NASDAQ:EDIT) Q1 2024 Earnings Call Transcript
insidermonkey.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from insidermonkey.com Daily Mail and Mail on Sunday newspapers.

United statesBrian chengMary kateErick luceraSamantha semenkowCristi barnettLinda burklyBristol myers squibbGreg whiteheadGilmore oneillMani forooharJack allenJoon leeEmmanuelle charpentierCaren deardorfBaisong mei

Editas Medicine, Inc (NASDAQ:EDIT) Q4 2023 Earnings Call Transcript

Editas Medicine, Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.52.

United statesGreg harrisonLinda burklyGilmore oneillBaisong meiCaren deardorfBrian chengErick luceraJoon leeCristi barnettSamantha semenkowCorporate communicationsEditas medicine incVertex pharmaceuticalsEditas medicineCall transcript february